Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer

BACKGROUND: Oxaliplatin resistance is a major challenge for treatment of advanced colorectal cancer (CRC). Both acquisition of epithelial-mesenchymal transition (EMT) and suppressed drug accumulation in cancer cells contributes to development of oxaliplatin resistance. Aberrant expression of small n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer
Autors principals: Liu, Tong, Zhang, Xin, Du, Lutao, Wang, Yunshan, Liu, Xiaoming, Tian, Hui, Wang, Lili, Li, Peilong, Zhao, Yinghui, Duan, Weili, Xie, Yujiao, Sun, Zhaowei, Wang, Chuanxin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423768/
https://ncbi.nlm.nih.gov/pubmed/30890168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-0981-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars